NCT03422900

Hyperglycemia in Patients with Stroke and Indication of Enteral Nutrition

Influence of Two Enteral Nutrition Formulas on Hyperglycemia and Morbidity in Patients with Stroke

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Endocrinology and Clinical Nutrition Research Center, Spain · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admission and enteral nutritional support by nasogastric tube. As well as the effect on metabolic control, development of comorbidities, hospital stay, readmissions, mortality and tolerance of the formula under study.

Detailed description

MAIN GOAL: To evaluate the effect on the development of hyperglycemia diagnosed as glycemia\> 126 mg / dl on an empty stomach or\> 150 mg / dl during the infusion of enteral nutrition determined by capillary glycemia during the admission of a specific formula in patients with a first episode of ischemic stroke or hemorrhagic entry into the non-diabetic HCUV stroke unit requiring enteral nutrition by nasogastric tube.

Conditions

• Hyperglycaemia (Non Diabetic)
• Enteral Feeding Intolerance
• Stroke

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Diabetes-Specific enteral formula	Complete enteral formula normocaloric hyperproteic with fiber (80% SOLUBLE)
DIETARY_SUPPLEMENT	Standard formula	Complete enteral formula normocaloric hormoproteic without fiber

Timeline

• Start date: 2017-12-12
• Primary completion: 2021-09-30
• Completion: 2021-09-30
• First posted: 2018-02-06
• Last updated: 2024-09-19

Locations

1 site across 1 country: Spain